Literature DB >> 27030267

The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.

Sandra Pinkert1, Carsten Röger2, Jens Kurreck2, Jeffrey M Bergelson3,4, Henry Fechner2.   

Abstract

UNLABELLED: The coxsackievirus and adenovirus receptor (CAR) is a member of the immunoglobulin superfamily (IgSF) and functions as a receptor for coxsackie B viruses (CVBs). The extracellular portion of CAR comprises two glycosylated immunoglobulin-like domains, D1 and D2. CAR-D1 binds to the virus and is essential for virus infection; however, it is not known whether D2 is also important for infection, and the role of glycosylation has not been explored. To understand the function of these structural components in CAR-mediated CVB3 infection, we generated a panel of human (h) CAR deletion and substitution mutants and analyzed their functionality as CVB receptors, examining both virus binding and replication. Lack of glycosylation of the CAR-D1 or -D2 domains did not adversely affect CVB3 binding or infection, indicating that the glycosylation of CAR is not required for its receptor functions. Deletion of the D2 domain reduced CVB3 binding, with a proportionate reduction in the efficiency of virus infection. Replacement of D2 with the homologous D2 domain from chicken CAR, or with the heterologous type C2 immunoglobulin-like domain from IgSF11, another IgSF member, fully restored receptor function; however, replacement of CAR-D2 with domains from CD155 or CD80 restored function only in part. These data indicate that glycosylation of the extracellular domain of hCAR plays no role in CVB3 receptor function and that CAR-D2 is not specifically required. The D2 domain may function largely as a spacer permitting virus access to D1; however, the data may also suggest that D2 affects virus binding by influencing the conformation of D1. IMPORTANCE: An important step in virus infection is the initial interaction of the virus with its cellular receptor. Although the role in infection of the extracellular CAR-D1, cytoplasmic, and transmembrane domains have been analyzed extensively, nothing is known about the function of CAR-D2 and the extracellular glycosylation of CAR. Our data indicate that glycosylation of the extracellular CAR domain has only minor importance for the function of CAR as CVB3 receptor and that the D2 domain is not essential per se but contributes to receptor function by promoting the exposure of the D1 domain on the cell surface. These results contribute to our understanding of the coxsackievirus-receptor interactions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030267      PMCID: PMC4886794          DOI: 10.1128/JVI.00315-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Picornavirus-receptor interactions.

Authors:  Michael G Rossmann; Yongning He; Richard J Kuhn
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

2.  Solution structure of the coxsackievirus and adenovirus receptor domain 1.

Authors:  Shaokai Jiang; Amy Jacobs; Thomas M Laue; Michael Caffrey
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

3.  Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

Authors:  Christopher J Cohen; Zhi Quan Xiang; Guang-Ping Gao; Hildegund C J Ertl; James M Wilson; Jeffrey M Bergelson
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

4.  The role of the extracellular domain in the biology of the coxsackievirus and adenovirus receptor.

Authors:  Katherine J D A Excoffon; Geri L Traver; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

5.  Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.

Authors:  A McClelland; J deBear; S C Yost; A M Meyer; C W Marlor; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

6.  Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.

Authors:  H Fechner; X Wang; H Wang; A Jansen; M Pauschinger; H Scherübl; J M Bergelson; H P Schultheiss; W Poller
Journal:  Gene Ther       Date:  2000-11       Impact factor: 5.250

7.  Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.

Authors:  Denise Werk; Sandra Pinkert; Albert Heim; Heinz Zeichhardt; Hans-Peter Grunert; Wolfgang Poller; Volker A Erdmann; Henry Fechner; Jens Kurreck
Journal:  Antiviral Res       Date:  2009-07-08       Impact factor: 5.970

Review 8.  N-linked oligosaccharides as outfitters for glycoprotein folding, form and function.

Authors:  Nivedita Mitra; Sharmistha Sinha; Thirumalai N C Ramya; Avadhesha Surolia
Journal:  Trends Biochem Sci       Date:  2006-02-10       Impact factor: 13.807

9.  The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.

Authors:  D E Staunton; M L Dustin; H P Erickson; T A Springer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 10.  Viral cell recognition and entry.

Authors:  M G Rossmann
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

View more
  6 in total

1.  The Coxsackievirus and Adenovirus Receptor, a Required Host Factor for Recovirus Infection, Is a Putative Enteric Calicivirus Receptor.

Authors:  Tibor Farkas; Kui Yang; Jacques Le Pendu; Joel D Baines; Rhonda D Cardin
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Coxsackievirus B Tailors the Unfolded Protein Response to Favour Viral Amplification in Pancreatic β Cells.

Authors:  Maikel L Colli; Flavia M Paula; Lorella Marselli; Piero Marchetti; Merja Roivainen; Decio L Eizirik; Anne Op de Beeck
Journal:  J Innate Immun       Date:  2019-02-20       Impact factor: 7.349

3.  Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps.

Authors:  Henry Fechner; Antje Beling; Sandra Pinkert; Anja Kopp; Vanessa Brückner
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

4.  CEACAM-1 promotes myocardial injury following coxsackievirus infection by regulating the coxsackievirus-adenovirus receptor.

Authors:  Zaiyong Zhang; Cheng Long; Xinzhong Li; Qiang Xie; Mingcai Song; Yulan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.

Authors:  Janik Böhnke; Sandra Pinkert; Maria Schmidt; Hans Binder; Nicole Christin Bilz; Matthias Jung; Uta Reibetanz; Antje Beling; Dan Rujescu; Claudia Claus
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

6.  Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.

Authors:  Sirika Pillay; Wei Zou; Fang Cheng; Andreas S Puschnik; Nancy L Meyer; Safder S Ganaie; Xuefeng Deng; Jonathan E Wosen; Omar Davulcu; Ziying Yan; John F Engelhardt; Kevin E Brown; Michael S Chapman; Jianming Qiu; Jan E Carette
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.